The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Archexin, a novel AKT-1–specific inhibitor for the treatment of metastatic renal cancer: Preliminary phase I data.

Scott T.  Tagawa

Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Medivation; Sanofi

Speakers' Bureau - Amgen

Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly (Inst); Millennium (Inst); Progenics (Inst); Sanofi (Inst)

Gurkamal S.  Chatta

No Relationships to Disclose

Reza  Mazhari

Employment - Cerecor; Rexahn Pharmaceuticals

Leadership - Cerecor; Rexahn Pharmaceuticals

Patents, Royalties, Other Intellectual Property - Cerecor

Ely  Benaim

Employment - Berg Pharma; Rexahn Pharmaceuticals

Leadership - Rexahn Pharmaceuticals